
    
      An estimated 20-65% of women treated with breast surgery for breast cancer experience chronic
      pain in the treated breast. Patients will be randomize between: infiltration with
      chlorhydrate of ropivacaine at the time of breast surgery for cancer versus
      placebo.Intra-operative analgesia will be standardized as well as peri-operative pain
      management.
    
  